IL33 and triple-negative breast carcinoma: ,134 Few studies have examined a potential role of interleukin-33 in triple-negative breast cancer risk and findings from these studies have variably found that interleukin-33 expression is higher in triple-negative breast cancer cell lines as compared to luminal cell lines and that increased expression of this marker is associated with improved survival in triple-negative breast cancer risk.135